Sumitomo Pharma Co., Ltd. (DNPUF)

OTCMKTS · Delayed Price · Currency is USD
14.36
-2.38 (-14.19%)
At close: Dec 12, 2025
247.70%
Market Cap6.41B
Revenue (ttm)3.01B
Net Income (ttm)1.05B
Shares Outn/a
EPS (ttm)2.63
PE Ratio6.13
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume219
Average Volume1,539
Open14.36
Previous Close16.74
Day's Range14.36 - 14.36
52-Week Range4.00 - 18.88
Beta0.54
RSI65.36
Earnings DateJan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has coll... [Read more]

Sector Healthcare
Founded 1897
Employees 3,832
Stock Exchange OTCMKTS
Ticker Symbol DNPUF
Full Company Profile

Financial Performance

Financial numbers in JPY Financial Statements

News

There is no news available yet.